๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
AI-Based Diabetic Foot Recurrence Cohort
NCT07452354Diabetic Foot Ulcer (DFU), Diabete Mellitus, Diabetic Foot Ulcer Treatment, Artificial Intelligence (AI) in Diagnosis
Peking University Third Hospital
Observational
200
Beijing
2026-03-15
Recruiting
Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial
NCT06326008B-cell Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse
Beijing GoBroad Hospital
Phase 1
48
Beijing
2026-03-15
Not yet open
A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire
NCT07054541Atrial Septal Defect (ASD)
Chinese Academy of Medical Sciences, Fuwai Hospital
Phase 4
666
Beijing
2026-03-14
Recruiting
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
NCT07412470Kidney Transplant Rejection
DrugsRabbit anti-thymocyte globulin·Frexalimab·Mycophenolate Mofetil·Tacrolimus
Sanofi
Phase 2/3
526
Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning, Shanghai
2026-03-13
Recruiting
Deep Cervical Lymphatic Venous Anastomosis in the Treatment of Alzheimer's Disease (CLEAN-AD)
NCT07073066Alzheimers Disease
Beijing Tiantan Hospital
Not applicable
376
Dongguan, Guangdong, Zhengzhou, Jinan, Jining, Ningbo, Beijing
2026-03-13
Recruiting
Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects
NCT07535099Health Services Research
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1
104
Beijing
2026-03-13
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
NCT07221149Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
DrugsCapox·Folfox·Pumitamig·Nivolumab
Bristol-Myers Squibb
Phase 2/3
690
Beijing, Fuzhou, Guangzhou, Nanning, Harbin, Weihui, Zhengzhou, Wuhan
2026-03-13
Active, closed
An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps
NCT07424144Chronic Rhinosinusitis With Nasal Polyps
DrugItepekimab
Sanofi
Phase 3
59
Baotou, Beijing, Chengdu, Jingzhou, Shenyang, Taiyuan
2026-03-12
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 โ‰ฅ 50%. (ROSETTA Lung-202)
NCT07361510Non-Small Cell Lung Cancer (NSCLC)
DrugsPumitamig·Pembrolizumab
Bristol-Myers Squibb
Phase 3
750
Beijing, Fuzhou, Xiamen, Zhangzhou, Guangzhou, Shantou, Nanning, Harbin
2026-03-12
Recruiting
Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models
NCT07500428Breast Neoplasms, Breast Diseases, Ultrasonography
Peking Union Medical College Hospital
Observational
1,380
Beijing
2026-03-12
Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
NCT07286058Psoriatic Arthritis
DrugZasocitinib
Takeda
Phase 3
1,182
Bengbu, Beijing, Guangzhou, Wuhan, Zhuzhou, Baotou Shi, Pingxiang, Linyi Shi
2026-03-11
Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
NCT07421700Urothelial Cancer, Advanced/Metastatic Urothelial Cancer, Urothelial Carcinoma
DrugsPF-08634404·Enfortumab Vedotin
Pfizer
Phase 1/2
132
Beijing, Nanjing, Tianjin, Ningbo
2026-03-11
Recruiting
Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors
NCT07631793Malignant Neoplasms
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Phase 1
76
Beijing
2026-03-10
Recruiting
Aortic No-Touch vs Partial Aortic Clamping in Off-Pump CABG
NCT07302659Coronary Artery Bypass Graft (CABG)
China National Center for Cardiovascular Diseases
Not applicable
380
Beijing, Qingdao, Shenzhen
2026-03-10
Recruiting
Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety
NCT07453862Restless Leg Syndrome (RLS), Variant Restless Legs Syndrome
Beijing Friendship Hospital
Phase 1
20
Beijing
2026-03-10
Recruiting
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery
NCT07458256Laparoscopic Surgery, Liposomal Bupivacaine, Local Infiltration
DrugsBupivacaine·Bupivacaine hydrochloride·Liposomal bupivacaine
Beijing Tiantan Hospital
Not applicable
190
Beijing
2026-03-10
Recruiting
Phase II Trial of RC1416 Injection in Asthma
NCT07403487Moderate to Severe Asthma
DrugRC1416
Nanjing RegeneCore Biotech Co., Ltd.
Phase 2
195
Anqing, Suzhou, Beijing, Chongqing, Lanzhou, Shijiazhuang, Tangshan, Xingtai
2026-03-10
Recruiting
The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology
NCT07458295Laparoscopic Surgery, Gynecologic Oncology Patient, Liposomal Bupivacaine, Transversus Abdominis Plane Block
DrugsBupivacaine·Bupivacaine hydrochloride·Liposomal bupivacaine
Beijing Tiantan Hospital
Not applicable
110
Beijing
2026-03-10
Recruiting
The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery
NCT07458282Laparoscopic Surgery, Liposomal Bupivacaine, Transversus Abdominis Plane Block
DrugsBupivacaine·Bupivacaine hydrochloride·Liposomal bupivacaine
Beijing Tiantan Hospital
Not applicable
318
Beijing
2026-03-10
Recruiting
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT07218341Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
DrugsIdelalisib·Pirtobrutinib
Eli Lilly and Company
Phase 4
150
Beijing, Changsha, Guangdong, Guangzhou, Lanzhou, Nanchang, Shanghai, Taizhou
2026-03-09
Recruiting
A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases
NCT07448298Relapsed/Refractory Autoimmune Diseases
DrugAFN50
Beijing Boren Hospital
Phase EARLY_PHASE1
18
Beijing
2026-03-09
Recruiting
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
NCT07431177Non-segmental Vitiligo
DrugGIA632
Novartis Pharmaceuticals
Phase 2
210
Guangzhou, Wuhan, Beijing, Shanghai
2026-03-09
Not yet open
A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixentยฎ) in Healthy Adult Male Subjects
NCT07334496Biosimilarity
DrugDupilumab
Gan & Lee Pharmaceuticals.
Phase 1
198
Beijing
2026-03-09
Recruiting
Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.
NCT07402213Chronic Spontaneous Urticaria
DrugJYB1904
Jemincare
Phase 3
240
Beijing
2026-03-09
Recruiting
Baricitinib for Post-HSCT Persistent Thrombocytopenia
NCT07535645Persistent Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation
DrugBaricitinib
Peking University People's Hospital
Phase 1/2
28
Beijing
2026-03-09
Not yet open
A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
NCT07349329Axial Spondyloarthritis, Non-Radiographic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 3
380
Beijing
2026-03-09
Recruiting
NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors
NCT07561437Advanced Solid Tumors
DrugNK521 Cell
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1
18
Beijing
2026-03-09
Recruiting
A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients
NCT07404202Pan-tumor(NSCLC, GYN Cancers, BTC and UC)
AstraZeneca
Observational
2,100
Beijing, Changsha, Chengdu, Guangzhou, Haerbin, Jinan, Nantong, Shanghai
2026-03-06
Recruiting
Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation
NCT07561554Solid Tumors (Phase 1)
DrugHSK42360-Na
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
159
Beijing
2026-03-06
Recruiting
CompaRison of FEmorofemoral Bypass and Left-Heart ByPass Techniques in Open Thoracoabdominal AortIc Aneurysm Repair
NCT07518251Thoracoabdominal Aortic Aneurysm, Cardiopulmonary Bypass, Open Repair
Beijing Anzhen Hospital
Not applicable
236
Beijing
2026-03-06
Recruiting
CAS for Stenosis With High-risk Features for CEA
NCT07370246Carotid Artery Stenosis, Carotid Artery Stenting
Beijing Tiantan Hospital
Not applicable
212
Beijing, Chongqing, Nanning, Guiyang, Shijiazhuang, Xingtai, Wuhan, Hohhot
2026-03-06
Recruiting
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
NCT07479732Osteosarcoma, Osteosarcoma Metastatic
DrugLiposomal Irinotecan
Peking University People's Hospital
Phase 1/2
56
Beijing
2026-03-05
Recruiting
ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy
NCT07453407Aortic Regurgitation, Aortic Valve Insufficiency, Aortic Insufficiency
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,250
Hefei, Beijing, Fuzhou, Guangzhou, Zhengzhou, Hong Kong, Wuhan, Changsha
2026-03-05
Not yet open
Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA)
NCT07484035Cow's Milk Protein Allergy (CMPA)
Heilongjiang Feihe Dairy Co. Ltd.
Not applicable
124
Beijing, Foshan, Zhuhai, Xiangtan, Wuxi, Chengdu
2026-03-05
Recruiting
A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants
NCT07462780Paroxysmal Nocturnal Hemoglobinuria, PNH, Complement-mediated Kidney Disease
Shenzhen Kangzhe Biotechnology Co., Ltd.
Phase 1
88
Beijing
2026-03-05
By invitation
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.
NCT07644403Epithelial Cancer Patients
Suzhou Immunofoco Biotechnology Co., Ltd
Phase 1/2
30
Beijing
2026-03-05
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
NCT07438496Lupus Erythematosus, Systemic
DrugNipocalimab
Janssen Research & Development, LLC
Phase 3
600
Beijing, Changsha, Cheng Du Shi, Dongguan, Guangzhou, Hangzhou, Hefei, Jinhua
2026-03-05
Not yet open
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction
NCT07406984Adenocarcinoma of Gastric, Adenocarcinoma of Esophagogastric Junction
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase 1
18
Beijing
2026-03-05
Recruiting
SKB105 for Injection in Advanced Solid Tumors
NCT07380386Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2
256
Beijing, Shanghai
2026-03-05
Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849CRC (Colorectal Cancer)
DrugsINCA33890·Folfox·Bevacizumab
Incyte Corporation
Phase 3
700
Beijing, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou
2026-03-05
Recruiting
A Study of TPD3310 in Patients With Advanced Malignant Tumors
NCT07368127Advanced Malignant Solid Tumors
TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD.
Phase 1
112
Beijing
2026-03-05
Recruiting
A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet
NCT07374224Clinical Pharmacology
DrugsRocbrutinib·Rifampicin·Itraconazole
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 1
28
Beijing
2026-03-05
Recruiting
Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors
NCT07400263Epithelial Tumors, Malignant
Peking University People's Hospital
Not applicable
30
Beijing
2026-03-04
Recruiting
A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.
NCT07658534Respiratory Syncytial Virus Infections
DrugZiresovir
Shanghai Ark Biopharmaceutical Co., Ltd.
Phase 2/3
290
Beijing, Guangzhou, Cangzhou, Nanyang, Zhengzhou, Wuhan, Hangzhou, Ruiโ€™an
2026-03-03
Recruiting
A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients
NCT07238894Ablation, Breast Cancer
Peking University People's Hospital
Not applicable
200
Beijing
2026-03-03
Recruiting
A Study of DXC014 in Patients With Advanced Solid Tumors.
NCT07177937Small Cell Lung Cancer, Melanoma, Prostate Cancer, Other Advanced Solid Tumors
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
150
Beijing, Changsha, Nanchang, Qingdao, Hangzhou
2026-03-03
Recruiting
This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.
NCT07249879Relapsed/Refractory Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
55
Beijing
2026-03-03
Recruiting
Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis
NCT07370909Moderate to Severe Atopic Dermatitis
Shanghai Longwood Biopharmaceuticals Co., Ltd.
Phase 3
480
Beijing
2026-03-03
Recruiting
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery
NCT07432711Video-assisted Thoracoscopic Surgery (VATS), Pain Management, Liposomal Bupivacaine, Local Injection
DrugsBupivacaine·Bupivacaine hydrochloride·Liposomal bupivacaine
Beijing Tiantan Hospital
Not applicable
100
Beijing
2026-03-02
Recruiting
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
NCT07374848Solid Tumors, Sarcomas
Zai Lab (Shanghai) Co., Ltd.
Phase 1
180
Beijing, Shanghai
2026-03-02
Recruiting
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma
NCT07436949Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
DrugBBT002
Bambusa Therapeutics
Phase 1/2
64
Beijing, Guangzhou, Changsha, Nanjing, Jinan, Qingdao, Yantai, Zibo
2026-03-02
Recruiting
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Hemorrhoid Surgery
NCT07442539Hemorrhoid Surgery, Liposome Bupivacaine, Pain Management, Local Infiltration
DrugsBupivacaine·Bupivacaine hydrochloride·Liposomal bupivacaine
Beijing Tiantan Hospital
Not applicable
156
Beijing
2026-03-02
Not yet open
Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers
NCT07438886Healthy Volunteer
DrugsAL3818·Ticagrelor·Itraconazole
Advenchen Laboratories Nanjing Ltd.
Phase 1
16
Beijing
2026-03-02
Recruiting
The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery
NCT07441902Video-assisted Thoracoscopic Surgery (VATS), Pain Management, Liposomal Bupivacaine, Rhomboid Intercostal Block
DrugsBupivacaine·Bupivacaine hydrochloride·Liposomal bupivacaine
Beijing Tiantan Hospital
Not applicable
134
Beijing
2026-03-02
Not yet open
A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis
NCT07436234Seasonal Allergic Rhinitis
DrugAK139
Akeso
Phase 2
111
Beijing
2026-03-02
By invitation
Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
NCT07454941Urothelial Carcinoma (UC), HER2, Diagnostic
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
4,000
Beijing
2026-03-02
Not yet open
IFN-ฮฑ in Relapse Prevention.
NCT07449286Acute Myeloid Leukemia, Myelodysplastic Syndromes
DrugIFN-ฮฑ
Peking University People's Hospital
Phase 2
100
Beijing
2026-03-01
Not yet open
Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke
NCT07423975Stroke Acute, Endovascular Treatment
DrugAnakinra
Beijing Tiantan Hospital
Phase 2
159
Beijing
2026-03-01
Not yet open
To Study the Safety and Efficacy of A Novel Intrauterine Estrogen-Releasing System in Induced Abortion
NCT07381569Abortion, Induced
Peking Union Medical College Hospital
Not applicable
200
Beijing
2026-03-01
Recruiting
A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer
NCT07506109BRAF V600E, Colorectal Cancer, Sintilimab, MSS (Microsatellite Stable)
DrugsIpilimumab N01·Dabrafenib·Pemetrexed·Tislelizumab
Tianjin Medical University Cancer Institute and Hospital
Phase 2
49
Beijing, Wuhan, Chengdu, Tianjin
2026-03-01
Active, closed
Diagnostic Value of EBUS-Guided Transbronchial Mediastinal Cryobiopsy Versus Conventional Bronchoscopic Approaches for Stage I/II Sarcoidosis
NCT07246876Sarcoidosis, Pulmonary
China-Japan Friendship Hospital
Not applicable
469
Beijing
2026-03-01
Recruiting
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
NCT07295275Liver Cancer
West China Hospital
Observational
200
Beijing, Xuzhou, Chengdu
2026-03-01
Not yet open
PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases
NCT07411781Colorectal Cancer, Adult
DrugTislelizumab
Chinese PLA General Hospital
Phase 1
25
Beijing
2026-03-01
Recruiting
The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis
NCT07203729HER2-Low Unresectable/Metastatic Breast Cancer Complicated With Visceral Crisis
DrugTrastuzumab Rezetecan
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
184
Beijing
2026-03-01
Not yet open
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Primary Sjogren Syndrome
NCT07375524Primary Sjรถgren Syndrome
DrugESG206
Shanghai Escugen Biotechnology Co., Ltd
Phase 2
40
Beijing, Xiamen, Guilin, Langfang, Changde, Changsha, Zhuzhou, Xuzhou
2026-03-01
Recruiting
Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
NCT07514897Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
250
Beijing
2026-03-01
Active, closed
Effect of Central Venous Catheterization on Brain Pressure in Acute Brain Injury Patients
NCT07704528Acute Brain Injury, Traumatic Brain Injury, Intracerebral Hemorrhage, Aneurysmal Subarachnoid Hemorrhage (aSAH)
Beijing Tiantan Hospital
Observational
120
Beijing, Guiyang
2026-03-01
Recruiting
GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.
NCT06558773Colorectal Cancer
DrugsEliglustat·Regorafenib
Chinese PLA General Hospital
Phase 2
120
Beijing
2026-03-01
Active, closed
A Study of VCT220 in Participants With Hypertension and Obesity or Overweight
NCT07360275Hypertension
DrugCX11
Vincentage Pharma Co., Ltd
Phase 2
160
Beijing
2026-03-01
Recruiting
Orelabrutinib in the Treatment of Relapsed/Refractory AIHA
NCT07453368Autoimmune Hemolytic Anemia (AIHA)
Peking Union Medical College Hospital
Phase 2
50
Beijing
2026-03-01
Recruiting
Discovery and Validation of Biomarkers for CSA-AKI Risk Prediction
NCT07811570CSA-AKI, Acute Kidney Injury, Cardiovascular Surgery, Biomarkers
China National Center for Cardiovascular Diseases
Observational
1,500
Beijing
2026-03-01
Recruiting
Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
NCT07460843Prostate Cancer (Diagnosis)
Peking University First Hospital
Not applicable
592
Beijing
2026-03-01
Not yet open
The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion
NCT07390032Acute Mild Basilar Artery Occlusion, Basilar Artery Occlusion, Endovascular Treatment
Feng Gao
Not applicable
230
Beijing
2026-03-01
Not yet open
TAVR for Aortic Regurgitation Under TEE Guidance
NCT07453849Aortic Regurgitation, Transcatheter Aortic Valve Replacement
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
30
Beijing
2026-03-01
Not yet open
Research, Development, and Application of Intelligent Diagnostic System for Orthostatic Hypotension
NCT07309666Orthostatic Hypotension
Xuanwu Hospital, Beijing
Observational
2,000
Beijing
2026-03-01
Not yet open
Predicting Post-Cardiac Surgery Acute Kidney Disease: A Machine Learning Approach
NCT07482683Acute Kidney Disease
China National Center for Cardiovascular Diseases
Observational
820
Beijing
2026-03-01
Recruiting
Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy
NCT07441850Gastric Cancer
Beijing Friendship Hospital
Not applicable
186
Beijing
2026-03-01
Not yet open
Development of A Multi-section Olfactory Cleft Opacity Staging System in Patients With CCAD
NCT07380945Central Compartment Atopic Disease (CCAD)
Peking University Third Hospital
Observational
120
Beijing
2026-03-01
Not yet open
Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer
NCT07397442Rectal Cancer, Adenocarcinoma, Rectal Cancer Stage II, Rectal Cancer Stage III
Beijing Friendship Hospital
Phase 2
19
Beijing
2026-03-01
Not yet open
The Effectiveness of Steroid Nasal Drops in the Olfactory Cleft Combined With Olfactory Training for Patients With PIOD
NCT07386860Smell Dysfunction
Peking University Third Hospital
Not applicable
100
Beijing
2026-03-01
Recruiting
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss
NCT07237750Overweight and/or Obesity, Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, Chinese
Liu Yan
Not applicable
216
Beijing
2026-03-01
Not yet open
Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone
NCT07381543Localized Small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Phase 2
76
Beijing
2026-03
Not yet open
Pharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function
NCT07457190Generalized Anxiety Disorder
DrugBuagafuran
Beijing Union Pharmaceutical Factory Ltd
Phase 1
24
Beijing
2026-03
Not yet open
Effect of Oral Supplement on Influenza Vaccine Long-term Response
NCT07357467Influenza, Immunosenescence
Tsinghua University
Observational
30
Beijing
2026-03
Not yet open
A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)
NCT07459556SAR
DrugStapokibart
Chengdu Kangnuoxing Biopharma,Inc.
Observational
400
Beijing
2026-03
Not yet open
Emergency Stroke Unit With NeuAngio-CT (ESU-ACT)
NCT07456228Acute Ischemic Stroke
Beijing Tiantan Hospital
Observational
500
Beijing
2026-03
Not yet open
Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement
NCT07411768Transcatheter Aortic Valve Replacement, Transcatheter Heart Valve Thrombosis, Anti-inflammatory Therapy
DrugColchicine
China National Center for Cardiovascular Diseases
Not applicable
116
Beijing
2026-03
Not yet open
The Phase I Study of SIG001 Antibody on Cancer Therapy.
NCT07486700Neoplams
Peking University
Phase 1
66
Beijing
2026-03
Not yet open
A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs
NCT07483684HER2 IHC3+ Advanced Colorectal Cancer
DrugTQB2102
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 3
142
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Meizhou
2026-03
Not yet open
Comparison of Radiofrequency Ablation With Concomitant or Staged Treatment for Tributary Varicose Veins
NCT07445425Varicose Veins of Lower Limb
Sir Run Run Shaw Hospital
Not applicable
206
Bengbu, Beijing, Nanning, Haikou, Zhengzhou, Zhoukou, Chenzhou, Huai'an
2026-03
Recruiting
IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors
NCT07441174Solid Tumor Cancer, PDAC
DrugsRNK08954·IN10018
InxMed (Shanghai) Co., Ltd.
Phase 1/2
92
Beijing, Fuzhou, Guangzhou, Zhengzhou, Luoyang, Changsha, Nanjing, Shengyang
2026-02-28
Not yet open
Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Perioperative Negative Emotions in Breast Cancer Surgery Patients
NCT07458646Depression, Postoperative, Anxiety, Breast Surgery
Chinese PLA General Hospital
Not applicable
232
Beijing
2026-02-28
Active, closed
RBD5044 in Chinese Participants With Hypertriglyceridemia
NCT07587788Hypertriglyceridemia
Ribotek Biopharmaceuticals (Shandong) Co., Ltd
Phase 2
40
Daqing, Harbin, Luoyang, Jingzhou, Nanyang, Yuncheng, Beijing
2026-02-28
Recruiting
A Retrospective Real-World Study Based on RATIONALE-307
NCT07478809NSCLC (Advanced Non-small Cell Lung Cancer)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
109
Beijing
2026-02-28
Recruiting
A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia
NCT07421297Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
DrugSYH2053
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 3
760
Beijing
2026-02-28
Not yet open
Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Delirium and Negative Emotions in Patients Undergoing Cardiac Surgery
NCT07476742Postoperative Delirium (POD), Postoperative, Anxiety, Depression
Chinese PLA General Hospital
Not applicable
270
Beijing
2026-02-28
Not yet open
Tanhuo Decoction for Acute Coronary Syndrome With Cerebral Atherosclerosis in Elderly Patients
NCT07445581Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis
Jinggang Xia, MD
Not applicable
480
Beijing
2026-02-28
Recruiting
A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer
NCT07294508HER2 + Breast Cancer
Shanghai Henlius Biotech
Phase 2/3
706
Beijing
2026-02-27
Recruiting
A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07327229Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
DrugsATG-022·Pembrolizumab KEYTRUDA·Capox
Antengene Biologics Limited
Phase 1/2
132
Hefei, Beijing, Fuzhou, Xiamen, Lanzhou, Langfang, Shijiazhuang, Anyang
2026-02-27
Recruiting
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
NCT07367529Advanced Lung Cancer
DrugTQB6411
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
465
Beijing, Chongqing, Guangzhou, Guanzhou, Zhongshan, Nanning, Cangzhou, Harbin
2026-02-26
Rows per page Showing 901–1000 of 5484
Previous 8 9 10 11 12 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=10

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.